Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol Combined With Rituximab in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Clinical trial NCT07693881 · RECRUITING
Trial details
- NCT number
- NCT07693881
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-12-31
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.